1ST CALL MOBILITY LIMITED

Company number 02144993 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

Financial Health Score: B+

Explanation: The patient exhibits a strong and stable corporate pulse, with excellent regulatory compliance and the robust backing of a major global healthcare group. However, the minimal share capital and the absence of detailed, standalone financial "blood work" (profit & loss figures) mean the entity is heavily reliant on its parent company for financial nourishment, which is typical for a subsidiary but warrants a slight reduction in independent financial vitality scoring.


Key Vital Signs

  • Corporate Pulse (Status & Age): Strong. Incorporated in 1987, this business has a long operational heartbeat of nearly 37 years. An "Active" status with no history of liquidation or administration indicates a resilient, long-standing business.
  • Regulatory Blood Pressure (Filing Compliance): Healthy. Both the annual accounts and the confirmation statement are fully up to date with no overdue filings. This shows a disciplined approach to administrative health, avoiding the penalties and fevers associated with regulatory non-compliance.
  • Genetic Lineage (Ownership & Control): Robust. The PSC register reveals that the company is ultimately controlled by Getinge Holding Limited and Huntleigh Technology Limited, with significant influence from Arjo Ab. These are substantial, multinational players in the medical device and equipment sector. The company operates under a strong corporate "immune system" provided by its parent group.
  • Capital Reserves (Share Capital): Minimal. The issued share capital is only £200. While this might look like a symptom of distress for an independent company, for a wholly-owned subsidiary, this is a standard genetic marker. It means the company relies on inter-company funding (loans from the parent) rather than its own share capital to finance operations.
  • Business DNA (Nature of Business): Adaptive. The company's SIC codes indicate a focus on the retail and leasing of medical and orthopaedic goods. Interestingly, previous names (Global Caravans Limited) show the business successfully mutated its DNA, pivoting from leisure/caravans to healthcare mobility—a highly resilient and essential market.

Diagnosis

Based on the available medical history and structural indicators, 1ST CALL MOBILITY LIMITED is a healthy subsidiary operating within a larger corporate anatomy.

The lack of publicly available detailed financial statements (Profit & Loss, detailed balance sheet) is a direct result of its "Small" company category, which allows it to file abbreviated accounts. This means we cannot measure its independent profitability or cash flow vitals. However, the structural diagnosis is positive: the company has been trading for nearly four decades, has successfully transitioned into a recession-resistant healthcare niche, and is well-protected under the umbrella of a global medical technology conglomerate.

There are no signs of director misconduct, no disqualification orders, and no symptoms of administrative distress. The minimal share capital is not a symptom of malnutrition, but rather a structural characteristic of being a group subsidiary, where the parent acts as the primary financial life-support system.


Recommendations

  1. Monitor Inter-Company "Transfusions": As a subsidiary with only £200 in share capital, the business will rely on inter-company loans or group cash pooling to fund its working capital. It is vital that management ensures these inter-company balances are properly documented and reviewed to maintain financial clarity within the group.
  2. Maintain Regulatory Hygiene: The company has an excellent track record of filing compliance. Continue to treat regulatory deadlines as preventative medicine—late filings can cause unnecessary fevers in the form of penalties and red flags with credit agencies.
  3. Evaluate Capital Structure: While £200 is sufficient legally, the directors may want to consider a bonus issue of shares or capitalising some of the retained profits/P&L reserves (if applicable) to strengthen the balance sheet's appearance to any external creditors or suppliers who may not immediately recognise the parent company guarantee.
  4. Niche Market Vigilance: Operating in the leasing and retail of medical mobility equipment requires keeping an eye on regulatory changes, equipment maintenance standards, and NHS/local authority procurement cycles. Ensure the business continues to adapt to the specific demands of its chosen healthcare niche.

Perspective: Financial Health Diagnostician · Model: glm-5.1 · Generated 11 September 2026